These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1431325)

  • 1. Leprosy immunopathogenesis and vaccine development.
    Chatterjee BR
    Indian J Lepr; 1992; 64(3):359-74. PubMed ID: 1431325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathogenesis of delayed-type hypersensitivity.
    Kobayashi K; Kaneda K; Kasama T
    Microsc Res Tech; 2001 May; 53(4):241-5. PubMed ID: 11340669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunobiology of leprosy.
    Kaplan G; Cohn ZA
    Int Rev Exp Pathol; 1986; 28():45-78. PubMed ID: 3516911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of IFN-gamma in delayed-type hypersensitivity mediated by Th1 clones.
    Fong TA; Mosmann TR
    J Immunol; 1989 Nov; 143(9):2887-93. PubMed ID: 2530282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis prevention: where do we go from here?
    Warndorff DK
    Afr Health; 1996 Nov; 19(1):21-2. PubMed ID: 12291917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
    Bretscher PA; Ogunremi O; Menon JN
    Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.
    Liew FY; Dhaliwal JS
    J Immunol; 1987 Jun; 138(12):4450-6. PubMed ID: 3295049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of Mycobacterium leprae soluble antigens to suppress delayed-type hypersensitivity reaction to tuberculin.
    Fine PE; Gruer PJ; Maine N; Ponnighaus JM; Rees RJ; Stanford JL
    Clin Exp Immunol; 1989 Aug; 77(2):226-9. PubMed ID: 2673590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed type hypersensitivity: current theories with an historic perspective.
    Black CA
    Dermatol Online J; 1999 May; 5(1):7. PubMed ID: 10673450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two distinct types of cellular mechanisms in the development of delayed hypersensitivity in mice: requirement of either mast cells or macrophages for elicitation of the response.
    Torii I; Morikawa S; Harada T; Kitamura Y
    Immunology; 1993 Mar; 78(3):482-90. PubMed ID: 8478030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cellular responses of tuberculosis and leprosy patients and of healthy controls in skin tests to 'new tuberculin' and leprosin A.
    Beck JS; Morley SM; Gibbs JH; Potts RC; Ilias MI; Kardjito T; Grange JM; Stanford J; Brown RA
    Clin Exp Immunol; 1986 Jun; 64(3):484-94. PubMed ID: 3539419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Schwann cells, T cells and Mycobacterium leprae in the immunopathogenesis of nerve damage in leprosy.
    Spierings E; De Boer T; Zulianello L; Ottenhoff TH
    Lepr Rev; 2000 Dec; 71 Suppl():S121-9. PubMed ID: 11201869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Under-explored experimental topics related to integral mycobacterial vaccines for leprosy.
    Gormus BJ; Meyers WM
    Expert Rev Vaccines; 2003 Dec; 2(6):791-804. PubMed ID: 14711362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones.
    Cher DJ; Mosmann TR
    J Immunol; 1987 Jun; 138(11):3688-94. PubMed ID: 2953788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 1 reactions in leprosy--heterogeneity in T-cell functions related to the background leprosy type.
    Laal S; Mishra RS; Nath I
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):481-93. PubMed ID: 2958570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.
    Shankar P; Agis F; Wallach D; Flageul B; Cottenot F; Augier J; Bach MA
    J Immunol; 1986 Jun; 136(11):4255-63. PubMed ID: 2422278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells.
    Ottenhoff TH; Elferink DG; Klatser PR; de Vries RR
    Nature; 1986 Jul 31-Aug 6; 322(6078):462-4. PubMed ID: 2426597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ; Closs O; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.